St Pancras Clinical Research (SPR) is a London-based Site Management Organisation which conducts clinical trials with new medicines for patients with neurodegenerative conditions resulting in chronic pain and/or memory disorders.
Our clinical and scientific specialists offer wide-ranging and practical expert advice to Sponsors on their drug development programmes, based individually upon 30+ years of experience in the public, private, academic and commercial pharma fields.
We (‘SPR’) will seek out the best ideas, science and talent and create a world class environment that stimulates creativity, encouraging innovation and collaboration to deliver medicines that make a difference to patients’ lives.
SPR’s first research clinic is three minutes walk from London’s largest rail and Tube hub (King’s Cross St Pancras) and adjacent to two University College London Hospitals NHS Foundation Trust specialist hospitals. Our screening and out-patient clinic is very accessible to any study participant coming from London and surrounding areas.
With a catchment area of 8.5 million inhabitants in Greater London, and a further 8 million across the South East, SPR has unrivalled subject recruitment potential. In addition, connections to both primary care and specialist centres in London will facilitate enrolment of patient groups that are typically more difficult to identify, thereby reducing recruitment costs.
We (‘SPR’) will seek out the best ideas, science and talent and create a world class environment that stimulates creativity, encouraging innovation and collaboration to deliver medicines that make a difference to patients’ lives.
